Foamix Pharma Ord
(FOMX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 4,999 | 415 | 598 | 1,408 | 0 |
| Cost of Goods | 377 | 150 | N/A | N/A | N/A |
| Gross Profit | 4,999 | 260 | 598 | 1,408 | N/A |
| Operating Expenses | 5,038 | 2,010 | 0 | 0 | 0 |
| Operating Income | 4,999 | -1,595 | 598 | 1,408 | N/A |
| Other Income | 0 | -6,245 | 0 | 0 | 0 |
| Pre-tax Income | 4,999 | -7,840 | 598 | 1,408 | 0 |
| Net Income Continuous | -3,637 | -7,847 | -3,432 | -41 | N/A |
| Net Income | $-3,637 | $-7,847 | $-3,432 | $-41 | $N/A |
| EPS Basic Total Ops | -0.18 | -0.61 | -0.30 | 0.00 | N/A |
| EPS Basic Continuous Ops | -0.18 | -0.61 | -0.30 | 0.00 | N/A |
| EPS Diluted Total Ops | -0.18 | -0.61 | -0.30 | 0.00 | N/A |
| EPS Diluted Continuous Ops | -0.18 | -0.61 | -0.30 | 0.00 | N/A |
| EBITDA(a) | $-29 | $-1,595 | $598 | $1,408 | $N/A |